A recent study demonstrates the greater treatment satisfaction of biologic users compared with non-biologic users for moderate-to-severe psoriasis. Given that nearly one-third of non-biologic users did not have enough information to form an opinion about biologic agents, physicians may consider counseling these patients on the use of biologic agents for psoriasis management. Researchers conducted a national survey from July to September 2016 on adult patients with moderate-to-severe psoriasis using biologic agents or non-biologic systemic agents as their current primary treatment modality. Patients were asked to evaluate their overall satisfaction with their treatment agent and their awareness of other treatment options. Responses from biologic and non-biologic systemic users were compared. They found:

• Overall, 343 participants were included (biologic users: n=218; non-biologic users: n=125).
• Biologic users had a higher overall satisfaction score than non-biologic users.
• With respect to treatment awareness, 30% of non-biologic patients did not have enough information to form an opinion about biologics.